10 Bone Density Factors to Monitor After 40

8. Medication Effects and Drug-Induced Bone Loss

Numerous medications commonly prescribed to adults over 40 can significantly impact bone metabolism and accelerate bone loss, making medication review and monitoring essential components of bone health management. Glucocorticoids (corticosteroids) represent the most well-known class of bone-damaging medications, with even low doses causing rapid bone loss through multiple mechanisms including decreased calcium absorption, increased calcium excretion, reduced osteoblast function, and increased osteoclast activity. Proton pump inhibitors (PPIs), widely used for acid reflux and peptic ulcer disease, can impair calcium absorption by reducing stomach acid production and have been associated with increased fracture risk, particularly with long-term use. Selective serotonin reuptake inhibitors (SSRIs) and other antidepressants may affect bone density through their influence on serotonin signaling pathways in bone cells, with some studies showing increased fracture risk in long-term users. Anticonvulsants can interfere with vitamin D metabolism and calcium absorption, while certain cancer treatments, including aromatase inhibitors and androgen deprivation therapy, dramatically reduce sex hormone levels and accelerate bone loss. Diuretics present a complex picture—thiazide diuretics may actually benefit bone health by reducing calcium excretion, while loop diuretics can increase calcium loss and negatively impact bone density. Anticoagulants, particularly heparin with long-term use, can cause significant bone loss, and even some over-the-counter medications like aluminum-containing antacids can interfere with calcium absorption when used regularly. The challenge lies in balancing the medical necessity of these medications with their potential bone health consequences, often requiring collaborative care between multiple healthcare providers to optimize both disease management and skeletal health through careful medication selection, dosing adjustments, and implementation of bone-protective strategies.